These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 400406)
1. [Fluocortolon, azathioprine and cyclophosphamide in the therapy of myasthenia gravis]. Jusić A; Zagar M Neurologija; 1979; 27(1-4):167-79. PubMed ID: 400406 [No Abstract] [Full Text] [Related]
2. [Treatment of myasthenia gravis with corticosteroids]. Denislic M; Jereb B; Trontelj JV Neurologija; 1978; 26(1-4):55-61. PubMed ID: 754042 [No Abstract] [Full Text] [Related]
3. Azathioprine in the treatment of myasthenia gravis. Witte AS; Cornblath DR; Parry GJ; Lisak RP; Schatz NJ Ann Neurol; 1984 Jun; 15(6):602-5. PubMed ID: 6742794 [TBL] [Abstract][Full Text] [Related]
4. [Corticosteroid therapy of polymyositis]. Nemet D; Stambuk D; Brzović Z; Plasaj M Neurologija; 1979; 27(1-4):221-6. PubMed ID: 262012 [No Abstract] [Full Text] [Related]
5. Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis. Cosi V; Lombardi M; Erbetta A; Piccolo G Acta Neurol (Napoli); 1993 Apr; 15(2):123-31. PubMed ID: 8328322 [TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive drug therapy in myasthenia gravis. Niakan E; Harati Y; Rolak LA Arch Neurol; 1986 Feb; 43(2):155-6. PubMed ID: 3947257 [TBL] [Abstract][Full Text] [Related]
7. [Comparative evaluation of the treatment of pemphigus with corticosteroids and corticosteroids combined with immunosuppressive agents]. Michałowski R; Kuczyńska L Przegl Dermatol; 1981; 68(2):227-32. PubMed ID: 7029660 [No Abstract] [Full Text] [Related]
8. High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies. Lin PT; Martin BA; Weinacker AB; So YT Muscle Nerve; 2006 Mar; 33(3):433-5. PubMed ID: 16116645 [TBL] [Abstract][Full Text] [Related]
9. [A post-thymomectomy case of myasthenia gravis which developed nephrotic syndrome with membranous nephropathy during azathioprine administration]. Konishi T; Miki S; Yoshida A; Tei M Rinsho Shinkeigaku; 1996 Jul; 36(7):864-8. PubMed ID: 8952354 [TBL] [Abstract][Full Text] [Related]
10. Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis. Kerkeni S; Marotte H; Miossec P Muscle Nerve; 2008 Oct; 38(4):1343-5. PubMed ID: 18816604 [No Abstract] [Full Text] [Related]
11. [Endocrinologic control of corticoid therapy in myasthenia gravis]. Tepavcević D; Mikulicić V; Tajić M; Jusić A Neurologija; 1979; 27(1-4):181-9. PubMed ID: 262007 [No Abstract] [Full Text] [Related]
12. [Controlled trial of cyclophosphamide, azathioprine and chlorambucil in lupus nephritis (the double-blind method)]. Ivanova MM; Nasonova VA; Solov'ev SK; Akhnazarova VD; Speranskiĭ AI Vopr Revm; 1981; (2):11-8. PubMed ID: 7034366 [No Abstract] [Full Text] [Related]
13. [Treatment of invasive thymoma with myasthenia gravis: a case report responsive to azathioprine and methylprednisolone]. Kumagai M; Kondou T; Handa M; Shiraishi Y; Fujimura S; Nakata T Kyobu Geka; 1990 Mar; 43(3):231-5. PubMed ID: 2319723 [TBL] [Abstract][Full Text] [Related]
14. [Side-effects of azathioprine and cyclophosphamide therapy]. Grgić Z Neurologija; 1979; 27(1-4):201-4. PubMed ID: 262009 [No Abstract] [Full Text] [Related]
16. Risk of malignancy in myasthenia gravis patients exposed to azathioprine therapy for a median period of 3 years. Rawoot A; Little F; Heckmann JM S Afr Med J; 2006 Dec; 96(12):1249-51. PubMed ID: 17252153 [No Abstract] [Full Text] [Related]
17. [Treatment of myasthenia gravis by immunosuppressive non-steroidal drugs]. De Assis JL; Marchiori PE; Scaff M; Zambon AA Arq Neuropsiquiatr; 1986 Jun; 44(2):109-16. PubMed ID: 3800686 [TBL] [Abstract][Full Text] [Related]